| Followers | 70 |
| Posts | 8967 |
| Boards Moderated | 0 |
| Alias Born | 03/06/2016 |
Sunday, November 26, 2023 12:44:14 PM
keep in mind the following..Wonder how much KG spent to commissioned said article?????
Dr. E. Antonio Chiocca is the Harvey Cushing Professor of Neurosurgery at Harvard Medical School
Ken Griffin, a billionaire hedge fund manager and philanthropist, has donated a total of over $550 million to Harvard University throughout his lifetime. His largest single donation was $300 million in 2023, which was given to the Faculty of Arts and Sciences (FAS) to support the School's mission and to advance cutting-edge research and expand access and excellence in education for students and scholars regardless of economic circumstances. In recognition of Griffin's commitment to Harvard's mission over the years, the Graduate School of Arts and Sciences was renamed the Harvard Kenneth C. Griffin Graduate School of Arts and Sciences in his honor.
Dr. E. Antonio Chiocca is the Harvey Cushing Professor of Neurosurgery at Harvard Medical School
Ken Griffin, a billionaire hedge fund manager and philanthropist, has donated a total of over $550 million to Harvard University throughout his lifetime. His largest single donation was $300 million in 2023, which was given to the Faculty of Arts and Sciences (FAS) to support the School's mission and to advance cutting-edge research and expand access and excellence in education for students and scholars regardless of economic circumstances. In recognition of Griffin's commitment to Harvard's mission over the years, the Graduate School of Arts and Sciences was renamed the Harvard Kenneth C. Griffin Graduate School of Arts and Sciences in his honor.
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
